Eur J Clin Chem Clin Biochem. 1996 Jan;34(1):17-22. Unique Identifier :
Prolyl oligopeptidase (EC 3.4.21.26) activity was measured in human
tissue homogenates and body fluids. The enzyme was ubiquitously present,
revealing high activity in renal cortex, epithelial cells, fibroblasts,
testis, lymphocytes and thrombocytes. The activity in the body fluids
was low. Prolyl oligopeptidase activity was significant higher in
tumours of prostate, lung and sigmoid, than in the healthy tissues. Sera
of individuals suffering from HIV infection, malaria, prostate cancer or
benign prostate hypertrophy contained lowered activity. Interestingly,
the low serum activity during prostate carcinoma increased upon medical
treatment with anti-androgens. This suggests hormonal control of the
gene transcript. A positive correlation with angiotensin converting
enzyme activity in hypertensive patients was demonstrated and this
further supports the possible involvement of prolyl oligopeptidase in
the renin-angiotensin system and in the pathogenesis of hypertension.
Acquired Immunodeficiency Syndrome/ENZYMOLOGY Amino Acid Sequence Body
Fluids/*ENZYMOLOGY Female Human Hypertension, Renal/ENZYMOLOGY Lung
Neoplasms/ENZYMOLOGY Malaria/ENZYMOLOGY Male Molecular Sequence Data
Peptidyl-Dipeptidase A/ANALYSIS Prostatic Hyperplasia/ENZYMOLOGY
Prostatic Neoplasms/ENZYMOLOGY Serine Proteinases/*ANALYSIS Support,
Non-U.S. Gov't Tissue Distribution JOURNAL ARTICLE